Inheriting the Bethune Spirit, Empowering New Development in Laboratory Medicine | Hotgen Biotech Shines at the 2026 Bethune Laboratory Medicine Conference

From May 15 to 17, 2026, the Council Meeting of the Laboratory Medicine Branch of the Bethune Spirit Research Association and the 8th Bethune Laboratory Medicine Conference were grandly held at the Steigenberger Hotel in Hefei, Anhui Province. With the core theme of "Inheriting the Red Gene, Carrying Forward the Bethune Spirit, and Becoming Laboratory Professionals of the New Era," the conference gathered more than a thousand experts and scholars in laboratory medicine, clinical backbone professionals, research institutions, and industry representatives from across the country. High-level academic exchanges were conducted around frontier directions including precision testing, smart laboratories, infection prevention and control, chronic disease management, early cancer screening, primary-level capacity building, ISO 15189 quality management, and AI-empowered laboratory testing — jointly advancing high-quality disciplinary development and safeguarding public health.

Hotgen Biotech was invited to participate in the full conference, deeply integrating into the event through academic exchanges, sub-forum participation, and product showcase. Together with industry peers, the company explored technology frontiers and discussed clinical value, practicing the Bethune spirit through innovative diagnostics and contributing to the advancement of laboratory medicine.

■ Grand Opening：Carrying Forward the Bethune Spirit and Painting a New Blueprint for Laboratory Medicine

The conference officially opened on the morning of May 16. President Dong Shukui and attending leaders delivered opening addresses, emphasizing that guided by the Bethune spirit, laboratory medicine should continue to achieve breakthroughs in standards building, smart upgrades, regional collaboration, and primary-level empowerment. The main venue featured presentations on major topics such as the construction of regional laboratory testing centers within closely integrated county-level medical communities, the research value of medical data, the AI-driven future of laboratory testing, the development of association standards, and the building of a laboratory medicine case database — forward-thinking in concept and substantial in content.

 (Embedded photo in the original web page: opening address by President Dong Shukui)

The conference simultaneously held 10 professional sub-forums covering the full spectrum of the field — microbiological immunity and oncology, infection and public health, cytokines, immune function assessment, chronic autoimmune diseases and health management, ISO 15189 quality management, AI-assisted cytological testing, AI-powered smart regional laboratories, coagulation and hemostasis, and point-of-care and emergency testing. A series of parallel activities were held, including satellite symposia, an enterprise achievements exhibition, a medical science popularization competition, and the "Bethune-style Laboratory / Laboratory Professional" commendation program, fully showcasing the latest achievements in China's laboratory medicine disciplinary development and humanistic heritage.

■ Academic Resonance: Focusing on Clinical Hotspots and Deep Engagement in Three Key Forums

During the conference, the sub-forums were filled with a strong academic atmosphere and gathered prominent experts, conducting in-depth discussions centered on clinical pain points and technology frontiers. (Embedded photos in the original web page: forum scenes)

Centering on pressing clinical needs such as non-invasive liver disease assessment, early liver cancer screening, precise fatty liver classification, and panoramic cytokine monitoring, Hotgen Biotech engaged in in-depth exchanges with attending experts on real-world application scenarios for frontier technologies, sharing integrated solutions closely aligned with clinical practice, and received wide recognition from the experts present.

■ Achievements Showcase: Full-Cycle Solutions Unveiled, Drawing High Industry Attention

The conference exhibition area brought together the frontier technologies and innovative achievements of outstanding enterprises at home and abroad, building an efficient platform for industry-university-research-application collaboration. Hotgen Biotech presented its mature products and integrated service capabilities in liver disease diagnosis, immune monitoring, and chemiluminescence. Key clinical-necessity solutions on display included the "Fatty Liver Duo" test (CK18-M30/CK18-M65), the "Liver Cancer Trio" (AFP/AFP-L3%/DCP), the C-GALAD risk early-warning model, and a series of cytokine testing panels — covering the full chain of needs from high-risk screening and precise diagnosis to full-cycle monitoring, combining precision, convenience, accessibility, and efficiency. The exhibits attracted many industry experts to stop, exchange ideas, and engage in in-depth discussion, fully demonstrating the company's technological depth and clinical service strength. 

(Embedded photo in the original web page: exchanges with guests at the Hotgen booth)

Laboratory medicine in the new era is the "vanguard" of precision medicine and a vital pillar of a Healthy China. Guided by clinical needs and driven by technological innovation, Hotgen Biotech remains committed to independent R&D and a quality-first principle, continuously deepening its breakthroughs in full-cycle liver disease management, precise immunological diagnosis, and smart laboratory testing. With reliable products and professional services, the company helps medical institutions enhance diagnostic capabilities, optimize diagnosis and treatment processes, reduce medical costs, and benefit more patients.